help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peters, G. A.
Right arrow Articles by Khan, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peters, G. A.
Right arrow Articles by Khan, S. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL
*TAMOXIFEN
Molecular Endocrinology 13 (2): 286-296
Copyright © 1999 by The Endocrine Society

Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140

Gregory A. Peters1 and Sohaib A. Khan

Department of Cell Biology, Neurobiology, and Anatomy University of Cincinnati College of Medicine Cincinnati, Ohio 45267

We have used the yeast two-hybrid system to localize the ligand-dependent dimerization domain of the estrogen receptor-{alpha} (ER) to region E in vivo. In this system, the cDNAs corresponding to the A–D, E, E/F, A–E ({Delta}F), and full-length (wtER) domains of the human ER were each cloned into the yeast two-hybrid vectors GAL4 DB and GAL4 TA and expressed in different combinations in yeast harboring a GAL1-lacZ reporter. The reporter was used as a relative measure of the interaction between the ER domains, through reconstitution of GAL4 activity. We found that the interaction of E or E/F domains of the ER with full-length ER is estradiol dependent and estrogen responsive element independent, as measured by the reconstitution of GAL4 activity from GAL4-E domain-containing fusion protein interactions. In the presence of F domain, this activity is reduced 10-fold. The results suggest that sequences in the F domain are inhibitory to the dimerization signal that is present in the E region. We propose that the full-length ER contains intrinsic dimerization restraints contributed by regions outside domain E that are released upon binding hormone agonist. In addition, we have demonstrated that coactivator RIP140 is able to interact with the ER in vivo at the E domain of the receptor in the presence of estrogen. Yeast two-hybrid analysis shows that RIP140 does not homodimerize in the presence or absence of estrogens. We present evidence showing that the ER has the inherent ability to interact with RIP140 in the presence of antiestrogens, but sequences inherent in the ER itself that are present outside of the E domain compromise this ability.




This article has been cited by other articles:


Home page
 Endocr Relat CancerHome page
D. J Kojetin, T. P Burris, E. V Jensen, and S. A Khan
Implications of the binding of tamoxifen to the coactivator recognition site of the estrogen receptor
Endocr. Relat. Cancer, December 1, 2008; 15(4): 851 - 870.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. T. Sonoda, L. Martinez, P. Webb, M. S. Skaf, and I. Polikarpov
Ligand Dissociation from Estrogen Receptor Is Mediated by Receptor Dimerization: Evidence from Molecular Dynamics Simulations
Mol. Endocrinol., July 1, 2008; 22(7): 1565 - 1578.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. M. Rytinki and J. J. Palvimo
SUMOylation Modulates the Transcription Repressor Function of RIP140
J. Biol. Chem., April 25, 2008; 283(17): 11586 - 11595.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Koide, C. Zhao, M. Naganuma, J. Abrams, S. Deighton-Collins, D. F. Skafar, and S. Koide
Identification of Regions within the F Domain of the Human Estrogen Receptor {alpha} that Are Important for Modulating Transactivation and Protein-Protein Interactions
Mol. Endocrinol., April 1, 2007; 21(4): 829 - 842.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. A. White, M. M. Yore, D. Deng, and M. J. Spinella
Limiting Effects of RIP140 in Estrogen Signaling: POTENTIAL MEDIATION OF ANTI-ESTROGENIC EFFECTS OF RETINOIC ACID
J. Biol. Chem., March 4, 2005; 280(9): 7829 - 7835.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
K. Kim, N. Thu, B. Saville, and S. Safe
Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells
Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817.
[Abstract] [Full Text] [PDF]

Home page
 Mol Biol EvolHome page
F. Bonneton, D. Zelus, T. Iwema, M. Robinson-Rechavi, and V. Laudet
Rapid Divergence of the Ecdysone Receptor in Diptera and Lepidoptera Suggests Coevolution Between ECR and USP-RXR
Mol. Biol. Evol., April 1, 2003; 20(4): 541 - 553.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
W.-C. Chou, V. Prokova, K. Shiraishi, U. Valcourt, A. Moustakas, M. Hadzopoulou-Cladaras, V. I. Zannis, and D. Kardassis
Mechanism of a Transcriptional Cross Talk between Transforming Growth Factor-beta -regulated Smad3 and Smad4 Proteins and Orphan Nuclear Receptor Hepatocyte Nuclear Factor-4
Mol. Biol. Cell, March 1, 2003; 14(3): 1279 - 1294.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli
A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation
Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. Tamrazi, K. E. Carlson, J. R. Daniels, K. M. Hurth, and J. A Katzenellenbogen
Estrogen Receptor Dimerization: Ligand Binding Regulates Dimer Affinity and DimerDissociation Rate
Mol. Endocrinol., December 1, 2002; 16(12): 2706 - 2719.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. A. Schwartz, L. Zhong, S. Deighton-Collins, C. Zhao, and D. F. Skafar
Mutations Targeted to a Predicted Helix in the Extreme Carboxyl-terminal Region of the Human Estrogen Receptor-alpha Alter Its Response to Estradiol and 4-Hydroxytamoxifen
J. Biol. Chem., April 5, 2002; 277(15): 13202 - 13209.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel
Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain
Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871.
[Abstract] [Full Text]

Home page
 Mol. Cell. Biol.Home page
J. Font de Mora and M. Brown
AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor
Mol. Cell. Biol., July 15, 2000; 20(14): 5041 - 5047.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
J. F. Couse and K. S. Korach
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
Endocr. Rev., June 1, 1999; 20(3): 358 - 417.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
A. Warnmark, T. Almlof, J. Leers, J.-A. Gustafsson, and E. Treuter
Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERalpha and ERbeta
J. Biol. Chem., June 22, 2001; 276(26): 23397 - 23404.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. A. Loven, V. S. Likhite, I. Choi, and A. M. Nardulli
Estrogen Response Elements Alter Coactivator Recruitment through Allosteric Modulation of Estrogen Receptor beta Conformation
J. Biol. Chem., November 21, 2001; 276(48): 45282 - 45288.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society